Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. | Chinese Medicine BioMed Central Research Prescription profile of potentially aristolochic acid containing Chinese herbal products an analysis of National Health Insurance data in Taiwan between 1997 and 2003 Shu-Ching Hsieh1 2 I-Hsin Lin3 Wei-Lum Tseng4 Chang-Hsing Lee2 5 and Jung-Der Wang 2 6 Address 1Division of Health Technology Assessment Center for Drug Evaluation Taiwan institute of Occupational Medicine and Industrial Hygiene College of Public Health National Taiwan University Taipei Taiwan 3Committee on Chinese Medicine and Pharmacy Department of Health Executive Yuan Taipei Taiwan 4Emergency Department of Taipei City Hospital Zhongxiao Branch Taipei Taiwan 5Department of Occupational Medicine Ton Yen General Hospital Hsinchu Taiwan and department of Internal Medicine and the Department of Environmental and Occupational Medicine National Taiwan University Hospital Taipei Taiwan Email Shu-Ching Hsieh - schsieh@ I-Hsin Lin - ihsin@ Wei-Lum Tseng - tsengweilum@ Chang-Hsing Lee - d95841004@ Jung-Der Wang - jdwang@ Corresponding author Open Access Published 23 October 2008 Received 20 February 2008 _ I Accepted 23 October 2008 Chinese Medicine 2008 3 13 doi 86 1749-8546-3-1 3 This article is available from http content 3 1 13 2008 Hsieh et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Some Chinese herbal products CHPs may contain aristolochic acid AA or may be adulterated by the herbs suspected of containing AA which is nephrotoxic and carcinogenic. This study aims to identify the risk and the prescription profile of AA-containing CHPs AA-CHPs in Taiwan. Methods A longitudinal analysis was conducted on
